NDC 17856-8083-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-8083
- Requested NDC
- 17856-8083-01
- Package NDCs from labels
- 17856-8083-1, 17856-8083-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACYCLOVIR ORAL SUSPENSION, USP Rx Only | ATLANTIC BIOLOGICALS CORP. | 2025-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-8083-1 | Acyclovir | 50 in 1 BOX, UNIT-DOSE | SUSPENSION | 50 | 1 | |
| 17856-8083-1 | Acyclovir | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 290af212-7332-4914-9ef0-65760478fb32 | 2024-10-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Golden State Medical Supply, Inc. | 0d99ba77-c3c5-1fd0-e063-6294a90a6f2a | 2024-09-30 | Warnings, Adverse reactions | X4HES1O11F |
| Household Detox | PTELEA TRIFOLIATA, ALLIUM SATIVUM, PETROLEUM, CARBONEUM SULPHURATUM, ALUMINA, BENZINUM, BISPHENOL A, CARBOLICUM ACIDUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PARAFFINUM, PHENACETINUM, SODIUM CARBOXYMETHYL CELLULOSE, FOLLICULINUM, ANTIPYRINUM, DIOXIN, DIETHYLSTILBESTROL, TEFLON | Deseret Biologicals, Inc. | 7e32c1f4-c88e-43d0-9f6c-de736d358d46 | 2024-09-27 | Warnings | K679OBS311 A2I8C7HI9T |
| hemorrhoidal maximum strength pain relief | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Kroger Company | 3c8f90e2-fecf-4439-9faa-81a32ffe4753 | 2024-09-26 | Warnings | PDC6A3C0OX |
| equate hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Wal-Mart Stores Inc | 5ccefdbd-bbbe-4cbf-9fdb-3c568643e14d | 2024-09-26 | Warnings | PDC6A3C0OX |
| Walgreens Hemorrhoidal Pain Relief | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Walgreens | e79ed7ae-0d06-2f88-e053-2995a90a1e35 | 2024-09-20 | Warnings | PDC6A3C0OX |
| Soothe | GLYCERIN AND PROPYLENE GLYCOL | Bausch & Lomb Incorporated | fef002ea-c4bd-4486-a42e-1bbd9d73d28d | 2024-09-20 | Warnings | PDC6A3C0OX |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e0f17e6f-63c7-4828-8585-91fc582df30b | 2024-09-06 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | f09cdb3f-dfd2-4e47-bb5e-a5d26d8bcc89 | 2024-09-06 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 8c5d1f30-2d31-417d-860b-7228b7baaa64 | 2024-09-06 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Golden State Medical Supply, Inc. | 785d68bc-0bbf-b69d-e053-2991aa0ac0d5 | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | af9d41f5-4658-4487-8811-32a1f8af9384 | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 89583890-186b-4a7a-8741-41f6c5f0a99d | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 01ae85df-d1a0-44f7-b4c0-0ac74d2216d4 | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Carlsbad Technology, Inc. | a68e610a-841c-4b69-9233-673d060561e8 | 2024-08-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Carlsbad Technology, Inc. | 37499620-6a17-40f1-b0db-dd79320ea21d | 2024-08-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | c46d5033-b1b2-e213-e053-2995a90ae6a3 | 2024-08-22 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 40e5cc54-ed74-3369-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | bb956f2b-627a-49bd-b258-4aac21d64b9a | 2024-08-14 | X4HES1O11F | |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | fdf6b492-a76e-4cea-89a1-a5b19c7938ff | 2024-08-14 | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.